0001711734-19-000001.txt : 20190613 0001711734-19-000001.hdr.sgml : 20190613 20190613161039 ACCESSION NUMBER: 0001711734-19-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20190613 DATE AS OF CHANGE: 20190613 EFFECTIVENESS DATE: 20190613 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Genome Medical Holding Co CENTRAL INDEX KEY: 0001750159 IRS NUMBER: 813033508 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-341872 FILM NUMBER: 19896212 BUSINESS ADDRESS: STREET 1: 95 THIRD STREET, SUITE 214 CITY: SAN FRANCISCO STATE: CA ZIP: 94103 BUSINESS PHONE: 877.688.0992 MAIL ADDRESS: STREET 1: 95 THIRD STREET, SUITE 214 CITY: SAN FRANCISCO STATE: CA ZIP: 94103 D 1 primary_doc.xml X0708 D LIVE 0001750159 Genome Medical Holding Co 701 Gateway Blvd. Suite 380 South San Francisco CA CALIFORNIA 94080 (877) 688-0992 DELAWARE Genome Medical, Inc. None Corporation true 2016 Lisa J. Alderson 701 Gateway Blvd. Suite 380 South San Francisco CA CALIFORNIA 94080 Executive Officer Director Randal W. Scott 701 Gateway Blvd. Suite 380 South San Francisco CA CALIFORNIA 94080 Director Robert C. Green 701 Gateway Blvd. Suite 380 South San Francisco CA CALIFORNIA 94080 Director Tim Howe 701 Gateway Blvd. Suite 380 South San Francisco CA CALIFORNIA 94080 Director Stephen Bloch 701 Gateway Blvd. Suite 380 South San Francisco CA CALIFORNIA 94080 Director Iana Dimkova 701 Gateway Blvd. Suite 380 South San Francisco CA CALIFORNIA 94080 Director Nicholas Naclerio 701 Gateway Blvd. Suite 380 South San Francisco CA CALIFORNIA 94080 Director Jessica Zeaske 701 Gateway Blvd. Suite 380 South San Francisco CA CALIFORNIA 94080 Director Other Health Care Decline to Disclose 06b false 2019-05-30 false true true Series B Preferred Stock and the Common Stock issuable upon the conversion thereof. false 0 22999990 22999990 0 false 16 0 0 0 false Genome Medical Holding Co /s/ Lisa J. Alderson Lisa J. Alderson Chief Executive Officer 2019-06-13